Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16278407 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: gefitinib

Indicates status has not been verified in more than two years